Advertisement

Topics

Ipsen Biopharmaceuticals Inc. Company Profile

05:21 EDT 24th September 2018 | BioPortfolio


News Articles [303 Associated News Articles listed on BioPortfolio]

Ipsen presents a range of data on Dysport in different therapy areas

Ipsen’s US-based biotech arm, Ipsen Biopharmaceuticals, says it will present data on Dysport (abobotulinumtoxinA)…

Ipsen Biopharma's Cabometyx tablets to treat adults with advanced RCC receives Canadian approval

Exelixis, Inc has announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of Cabometyx (cabozantinib) tablets for the treatment of adults with advanced ren...

Ipsen Announces Clinical Data to Be Presented at ASCO Demonstrating Its Commitment to Patients ...

IpsenMediaIan WeatherheadVice President, Corporate External Communications+44 (0) 1753 627733ian.weatherhead@ipsen.comorBrigitte Le GuennecSenior Manager, Global External Communications+...

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Exelixis, Inc. today announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of CABOMETYX® tablets for the treatment of adults with advanced renal cell ca...

Ipsen appoints new general manager for the UK & Ireland

The French pharma company appointed a new general manager for its UK and Ireland office, Asad Mohsin Ali, who brings two decades of commercial experience and a bold vision for Ipsen’s global footpri...

Ipsen Dreams Of Capital Position In Oncology

Ipsen's chief medical officer Sotirios Stergiopoulos talks about the company's R&D and licensing strategy that he hopes will push Ipsen's...   

Ipsen and BioLabs to open new Innovation Center in Cambridge (U.S. ...

Ipsen Innovation Center – BioLabs to be located in Ipsen’s new and third global hub in the heart of Cambridge, Massachusetts Read more...

Ipsen And BioLabs To Open New Innovation Center To Foster Development Of New Therapies

NewsThe shared laboratory space, called the ‘Ipsen Innovation Center - BioLabs’ (IPSEN-ICB) will be a fully equipped 15,000 square-feet combined office and laboratory facility dedicated to support...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Thrombin human [Ethicon, Inc]

These highlights do not include all the information needed to use EVITHROM safely and effectively. See full prescribing information for EVITHROM.EVITHROM, Thrombin, Topical (Human)For Topical Use Only...

Somatuline depot [Beaufour Ipsen Pharma SAS]

Somatuline Depot (lanreotide) Injection

PubMed Articles [40 Associated PubMed Articles listed on BioPortfolio]

Surfactants as Stabilizers for Biopharmaceuticals: An Insight into the Molecular Mechanisms for Inhibition of Protein Aggregation.

Surfactants are common stabilizers, often added to biopharmaceuticals formulations, but the mechanisms at the basis of their activity are unclear. The aim of this work is to provide insight into the m...

Next Generation Biopharmaceuticals: Product Development.

Therapeutic proteins show a rapid market growth. The relatively young biotech industry already represents 20 % of the total global pharma market. The biotech industry environment has traditionally bee...

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

Characterisation of protein aggregation with the Smoluchowski coagulation approach for use in biopharmaceuticals.

Protein aggregation is a field of increasing importance in the biopharmaceutical industry. Aggregated particles decrease the effectiveness of the drug and are associated with other risks, such as incr...

Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection.

Physicochemical and structural properties of proteins used as active pharmaceutical ingredients of biopharmaceuticals are determinant to carry out their biological activity. In this regard, the assays...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Administration of GnRH Antagonist to Oocyte Donation Recipients

This prospective and randomized study was performed to evaluate whether the replacement of GnRH agonist by a GnRH antagonist in oocyte donation recipients during endometrial preparation h...

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders

The purpose of this study is to compare ovulation induction using a flexible GnRH antagonist protocol and flare up GnRH agonist protocol in IVF patients with poor response to ovarian stimu...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

The purpose of this study is to compare pregnancy rates and the occurrence of OHSS in PCOS patients who were treated with GnRH agonist and GnRH antagonist protocols ovarian stimulation dur...

Companies [198 Associated Companies listed on BioPortfolio]

Ipsen Biopharmaceuticals Inc.

Ipsen N.A.

Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding €1.2 billion in 2013. Ipsen’s ambition is to become a leader in specialty healthcare...

Ipsen S.A.

Ipsen is a global biopharmaceutical group, with sales exceeding 1 billion euros in 2009. The Group has total worldwide staff of more than 4,400 employees, of which nearly 900 cont...

The Fondation IPSEN

Established in 1983 under the aegis of the Fondation de France, the ambition of the Fondation IPSEN is to initiate a reflection about the major scientific issues of the forthcomin...

Ipsen

Ipsen is a global biopharmaceutical group with total sales in excess of 1 billion euros in 2009, and total worldwide staff of more than 4,400. Its strategy is based on fast growin...

More Information about "Ipsen Biopharmaceuticals Inc." on BioPortfolio

We have published hundreds of Ipsen Biopharmaceuticals Inc. news stories on BioPortfolio along with dozens of Ipsen Biopharmaceuticals Inc. Clinical Trials and PubMed Articles about Ipsen Biopharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ipsen Biopharmaceuticals Inc. Companies in our database. You can also find out about relevant Ipsen Biopharmaceuticals Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record